JSP191 Antibody Conditioning Regimen in MDS/AML Subjects Undergoing Allogenic Hematopoietic Stem Cell Transplantation

NCT04429191 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

MYELODYSPLASTIC SYNDROME; MDS
ACUTE MYELOID LEUKEMIA; AML

Interventions

BIOLOGICAL: Humanized anti-CD117 Monoclonal Antibody (JSP191)

Sponsor

Jasper Therapeutics, Inc.